相似文献
1
Pneumococcal Vaccination Strategies Among HIV-infected Adult Patients: A Review of the Literature.
In Vivo. 2019 Sep-Oct;33(5):1425-1430. doi: 10.21873/invivo.11620.
2
Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.
Hum Vaccin Immunother. 2014;10(12):3700-10. doi: 10.4161/hv.32247.
3
Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy.
Hum Vaccin Immunother. 2013 Feb;9(2):398-404. doi: 10.4161/hv.22836. Epub 2013 Jan 4.
4
Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.
Am J Epidemiol. 2017 Aug 15;186(4):435-444. doi: 10.1093/aje/kwx048.
5
Temporal Changes in Pneumococcal Colonization in HIV-infected and HIV-uninfected Mother-Child Pairs Following Transitioning From 7-valent to 13-valent Pneumococcal Conjugate Vaccine, Soweto, South Africa.
J Infect Dis. 2015 Oct 1;212(7):1082-92. doi: 10.1093/infdis/jiv167. Epub 2015 Mar 17.
6
Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Clin Infect Dis. 2017 Jan 15;64(2):175-183. doi: 10.1093/cid/ciw720. Epub 2016 Oct 21.
7
Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.
Vaccine. 2013 Dec 5;31(50):6011-21. doi: 10.1016/j.vaccine.2013.10.024. Epub 2013 Oct 19.
8
Pneumococcal conjugate vaccine failure in children: A systematic review of the literature.
Vaccine. 2016 Dec 7;34(50):6126-6132. doi: 10.1016/j.vaccine.2016.10.050. Epub 2016 Nov 9.
9
Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.
Vaccine. 2012 Sep 7;30 Suppl 3:C21-7. doi: 10.1016/j.vaccine.2012.05.055.
10
Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.
Pediatrics. 2003 Jul;112(1 Pt 1):66-73. doi: 10.1542/peds.112.1.66.
引用本文的文献
1
Living with HIV and Getting Vaccinated: A Narrative Review.
Vaccines (Basel). 2023 Apr 25;11(5):896. doi: 10.3390/vaccines11050896.
本文引用的文献
1
A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly.
Hum Vaccin Immunother. 2019;15(1):249-255. doi: 10.1080/21645515.2018.1509648. Epub 2018 Sep 21.
2
HIV-related pneumococcal disease prevention in adults.
Expert Rev Respir Med. 2017 Mar;11(3):181-199. doi: 10.1080/17476348.2017.1289841. Epub 2017 Feb 21.
3
Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System.
AIDS Patient Care STDS. 2016 Oct;30(10):463-470. doi: 10.1089/apc.2016.0165.
4
Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.
Hum Vaccin Immunother. 2014;10(12):3700-10. doi: 10.4161/hv.32247.
5
Pneumococcal immunization in immunocompromised hosts: where do we stand?
Expert Rev Vaccines. 2014 Jan;13(1):59-74. doi: 10.1586/14760584.2014.859990. Epub 2013 Dec 4.
6
Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil.
Vaccine. 2013 Aug 20;31(37):4047-53. doi: 10.1016/j.vaccine.2013.04.065. Epub 2013 May 16.
7
Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy.
Hum Vaccin Immunother. 2013 Feb;9(2):398-404. doi: 10.4161/hv.22836. Epub 2013 Jan 4.
8
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.
BMC Public Health. 2012 Mar 22;12:222. doi: 10.1186/1471-2458-12-222.
9
Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals.
Hum Vaccin Immunother. 2012 Feb;8(2):161-73. doi: 10.4161/hv.18432. Epub 2012 Feb 1.
10
Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002-2009.
Epidemiol Infect. 2012 Jul;140(7):1252-66. doi: 10.1017/S0950268811001907. Epub 2011 Nov 1.
Zotero 插件